Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Surg Today ; 53(10): 1149-1159, 2023 Oct.
Article in English | MEDLINE | ID: mdl-36961609

ABSTRACT

PURPOSE: The albumin-bilirubin (ALBI) grade is calculated using albumin and bilirubin values. We determined the optimal cutoff value of the ALBI grade for predicting the postoperative prognosis of gastric cancer (GC). METHODS: We retrospectively reviewed a multicenter database of 3571 patients who underwent gastrectomy for GC between January 2010 and December 2014. The modified ALBI (mALBI) grade was determined using cutoff values: grade 1 (mALBI ≤ - 2.70), 2 (mALBI - 2.70 to - 2.10), and 3 (mALBI > - 2.10). We used a validation cohort to evaluate reproducibility. RESULTS: The entire cohort (n = 956) was randomly assigned to the learning or validation cohorts (n = 478 each). The former was categorized into the following groups by the preoperative mALBI grade: grade 1 (n = 235), grade 2 (n = 162), and grade 3 (n = 81). The disease-specific survival (DSS) rates of the learning and validation cohorts were significantly shortened in association with higher mALBI grade (learning, p = 0.0068; validation, p = 0.0100). A multivariate analysis revealed that mALBI grade 3 served as an independent prognostic factor for DSS. Furthermore, mALBI grade 2 or 3 was associated with a greater risk of disease-specific death in most subgroups. CONCLUSION: The mALBI grade accurately predicted the long-term postoperative prognosis of locally advanced GC.


Subject(s)
Carcinoma, Hepatocellular , Liver Neoplasms , Stomach Neoplasms , Humans , Bilirubin , Serum Albumin , Stomach Neoplasms/surgery , Retrospective Studies , Reproducibility of Results , Prognosis , Risk Assessment , Liver Neoplasms/surgery , Carcinoma, Hepatocellular/surgery
2.
Dig Surg ; 37(5): 401-410, 2020.
Article in English | MEDLINE | ID: mdl-32344400

ABSTRACT

BACKGROUND: Curative treatment for gastric cancer (GC) comprising gastrectomy with systematic lymph node dissection can result in postoperative complications. Postoperative pneumonia is sometimes fatal, like surgery-related complications such as anastomotic leakage. In this retrospective study, we analyzed a multi-institutional collaborative dataset with the aim of identifying predictors of postgastrectomy pneumonia. METHODS: From a retrospective database of 3,484 patients who had undergone gastrectomy for GC at nine Japanese institutions between 2010 and 2014, 1,415 patients who met all eligibility criteria were identified as eligible for analysis. Predictive values of 31 candidate variables for postoperative pneumonia were assessed. RESULTS: Forty-two patients (3.0%) had grade II or higher postoperative pneumonia. Preoperative systemic inflammation score (SIS) had the greatest area under the curve (0.655) for predicting postoperative pneumonia (optimal cutoff value = 2). The odds ratio (OR) of high SISs associated with postoperative pneumonia was 3.10 (95% confidence interval [CI], 1.54-6.07; p < 0.001). Multivariate binomial logistic analysis identified high SIS as an independent risk factor for postoperative pneumonia (OR, 2.31; 95% CI, 1.19-4.48; p = 0.013). A forest plot revealed that ORs of high SISs were highest in female patients. CONCLUSIONS: Our findings indicate that the preoperative SIS may serve as a simple predictor of postgastrectomy pneumonia, assisting physicians' efforts to take preventive measures against this complication.


Subject(s)
Gastrectomy/adverse effects , Inflammation/blood , Lymphocytes , Monocytes , Pneumonia/etiology , Stomach Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Area Under Curve , Female , Humans , Lymph Node Excision/adverse effects , Lymphocyte Count , Male , Middle Aged , Postoperative Complications/etiology , Predictive Value of Tests , Preoperative Period , ROC Curve , Retrospective Studies , Risk Factors , Serum Albumin/metabolism , Sex Factors
3.
Nagoya J Med Sci ; 79(1): 75-83, 2017 02.
Article in English | MEDLINE | ID: mdl-28303064

ABSTRACT

Aneurysm formation is a potential complication of granulomatosis with polyangiitis (GPA), previously known as Wegener's granulomatosis. It is a very rare complication, but immediate diagnosis and therapy should be performed because an aneurysm can be life-threatening if it ruptures. An accessory left gastric artery (ALGA) is also a rare variant gastric artery that may obtain its blood supply from the left hepatic artery and left gastric artery. We herein describe a 57-year-old Japanese man who was diagnosed with GPA complicated by aneurysm rupture in an ALGA. Emergency surgery was performed after failure of arterial coil embolization to interrupt blood flow in the ALGA. The patient underwent partial resection of the lesser omentum, which contained all aneurysms. During partial resection of the lesser omentum, both the left gastric artery and ALGA were ligated because they were thought to be feeders of the aneurysms. Postoperative recovery was uneventful; no bleeding or recurrence of the aneurysms occurred. Immediate diagnosis and therapy should be performed for patients with GPA with symptoms of vascular ischemia or aortitis. Endovascular intervention is the first-choice therapy especially for hemodynamically stable patients with ruptured aneurysms or aneurysms located on variant arteries, which may have multiple blood supplies. In the present case, although endovascular treatment failed, the approach described herein was helpful during open surgery.


Subject(s)
Aneurysm, Ruptured/diagnosis , Gastric Artery/pathology , Granulomatosis with Polyangiitis/complications , Aneurysm, Ruptured/etiology , Female , Humans , Male , Postoperative Period
4.
Gan To Kagaku Ryoho ; 43(7): 905-7, 2016 Jul.
Article in Japanese | MEDLINE | ID: mdl-27431639

ABSTRACT

A73 -year-old man underwent a sigmoidectomy for sigmoid colon cancer with liver metastasis. After the operation, he received CapeOX combined with bevacizumab therapy. After 6 courses, the liver metastasis was undetectable on computed tomography scans. After 15 courses, computed tomography revealed ascites, and chemotherapy was discontinued. Two months later, computed tomography revealed portal vein thrombosis. Owing to the chronic nature of the thrombosis, thrombolytic therapy was not initiated. However, preservation therapy using antiplatelet drugs for 1 month resolved the ascites and the thrombosis. The risk of serious thrombosis must be considered when using bevacizumab.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Capecitabine/adverse effects , Liver Neoplasms/drug therapy , Portal Vein/diagnostic imaging , Sigmoid Neoplasms/drug therapy , Venous Thrombosis/chemically induced , Aged , Aspirin/therapeutic use , Bevacizumab/administration & dosage , Capecitabine/administration & dosage , Humans , Liver Neoplasms/secondary , Male , Organoplatinum Compounds/administration & dosage , Oxaliplatin , Platelet Aggregation Inhibitors/therapeutic use , Sigmoid Neoplasms/pathology , Sigmoid Neoplasms/surgery , Tomography, X-Ray Computed , Treatment Outcome , Venous Thrombosis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL